Nature Communications Medicine Publishes Positive, Real World Data for Tinnitus Patients Treated with Unique, FDA Approved Stimulation Device

Neuromod Devices Austria Belgium France Germany Italy Netherlands Spain Switzerland United Kingdom Illinois United States of America

91.5% of patients experienced clinically meaningful reductions in tinnitus after 12 weeks of treatment with Lenire.220 patients were analyzed, making the paper one of the largest real-world analyses of tinnitus patients ever published in a peer-reviewed scientific journal.Real-world outcomes in this paper are consistent with the results of Lenire's large-scale clinical trials.View original content:https://www.prnewswire.co.uk/news-releases/nature-communications-medicine-publishes-positive-real-world-data-for-tinnitus-patients-treated-with-unique-fda-approved-stimulation-device-302439626.html